comparemela.com
Home
Live Updates
FDA Grants Fast Track Designation to CAN-3110 for Recurrent High-Grade Glioma : comparemela.com
FDA Grants Fast Track Designation to CAN-3110 for Recurrent High-Grade Glioma
CAN-3110, an HSV-1 oncolytic viral immunotherapy candidate, has received FDA fast track designation for adult patients with recurrent high-grade glioma.
Related Keywords
Massachusetts ,
United States ,
Boston ,
Antonio Chiocca ,
Harvard Medical School ,
Department Of Neurosurgery At Brigham ,
Peter Tak ,
Candel Therapeutics ,
Can 3110 ,
Adult Patients With Recurrent High Grade Glioma ,
Paul Peter Tak ,
D ,
Phd ,
Medsci ,
Brigham And Womens Hospital ,
comparemela.com © 2020. All Rights Reserved.